Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks.

Manning SD, Motiwala AS, Springman AC, Qi W, Lacher DW, Ouellette LM, Mladonicky JM, Somsel P, Rudrik JT, Dietrich SE, Zhang W, Swaminathan B, Alland D, Whittam TS.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4868-73. doi: 10.1073/pnas.0710834105.

2.
3.
4.
5.
6.

Relevance of neutrophils in the murine model of haemolytic uraemic syndrome: mechanisms involved in Shiga toxin type 2-induced neutrophilia.

Fernandez GC, Lopez MF, Gomez SA, Ramos MV, Bentancor LV, Fernandez-Brando RJ, Landoni VI, Dran GI, Meiss R, Isturiz MA, Palermo MS.

Clin Exp Immunol. 2006 Oct;146(1):76-84.

7.

Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.

Robinson CM, Sinclair JF, Smith MJ, O'Brien AD.

Proc Natl Acad Sci U S A. 2006 Jun 20;103(25):9667-72.

8.

Complexity of the genomic diversity in enterohemorrhagic Escherichia coli O157 revealed by the combinational use of the O157 Sakai OligoDNA microarray and the Whole Genome PCR scanning.

Ogura Y, Kurokawa K, Ooka T, Tashiro K, Tobe T, Ohnishi M, Nakayama K, Morimoto T, Terajima J, Watanabe H, Kuhara S, Hayashi T.

DNA Res. 2006 Feb 28;13(1):3-14.

PMID:
16766508
9.

Haemolytic uraemic syndrome: an overview.

Amirlak I, Amirlak B.

Nephrology (Carlton). 2006 Jun;11(3):213-8. Review.

PMID:
16756634
10.

Ecological and evolutionary forces shaping microbial diversity in the human intestine.

Ley RE, Peterson DA, Gordon JI.

Cell. 2006 Feb 24;124(4):837-48. Review.

11.

Enterohaemorrhagic Escherichia coli in human medicine.

Karch H, Tarr PI, Bielaszewska M.

Int J Med Microbiol. 2005 Oct;295(6-7):405-18. Review.

PMID:
16238016
12.

Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota.

Kuehl CJ, Wood HD, Marsh TL, Schmidt TM, Young VB.

Infect Immun. 2005 Oct;73(10):6952-61.

13.

Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.

Sheoran AS, Chapman-Bonofiglio S, Harvey BR, Mukherjee J, Georgiou G, Donohue-Rolfe A, Tzipori S.

Infect Immun. 2005 Aug;73(8):4607-13.

14.

Analysis of the large bowel microbiota of colitic mice using PCR/DGGE.

Bibiloni R, Simon MA, Albright C, Sartor B, Tannock GW.

Lett Appl Microbiol. 2005;41(1):45-51.

15.
16.

Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Tarr PI, Gordon CA, Chandler WL.

Lancet. 2005 Mar 19-25;365(9464):1073-86. Review.

PMID:
15781103
17.
18.

The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.

Takahashi M, Taguchi H, Yamaguchi H, Osaki T, Komatsu A, Kamiya S.

FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):219-26.

19.

Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7.

Asahara T, Shimizu K, Nomoto K, Hamabata T, Ozawa A, Takeda Y.

Infect Immun. 2004 Apr;72(4):2240-7.

20.

Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin.

Ikeda M, Ito S, Honda M.

Pediatr Nephrol. 2004 May;19(5):485-9.

PMID:
15007712
Items per page

Supplemental Content

Support Center